User profiles for Ning-Yi Shao

Ning-Yi Shao

University of Macau
Verified email at umac.mo
Cited by 4627

[HTML][HTML] Comprehensive survey of human brain microRNA by deep sequencing

NY Shao, HY Hu, Z Yan, Y Xu, H Hu, C Menzel, N Li… - BMC genomics, 2010 - Springer
Background MicroRNA (miRNA) play an important role in gene expression regulation. At
present, the number of annotated miRNA continues to grow rapidly, in part due to advances of …

[HTML][HTML] diffReps: detecting differential chromatin modification sites from ChIP-seq data with biological replicates

L Shen, NY Shao, X Liu, I Maze, J Feng, EJ Nestler - PloS one, 2013 - journals.plos.org
ChIP-seq is increasingly being used for genome-wide profiling of histone modification marks.
It is of particular importance to compare ChIP-seq data of two different conditions, such as …

A comprehensive TALEN-based knockout library for generating human-induced pluripotent stem cell–based models for cardiovascular diseases

…, M Ameen, R Shrestha, H Wu, N Ma, NY Shao… - Circulation …, 2017 - Am Heart Assoc
Rationale: Targeted genetic engineering using programmable nucleases such as
transcription activator–like effector nucleases (TALENs) is a valuable tool for precise, site-specific …

β-catenin mediates stress resilience through Dicer1/microRNA regulation

C Dias, J Feng, H Sun, NY Shao, MS Mazei-Robison… - Nature, 2014 - nature.com
β-catenin is a multi-functional protein that has an important role in the mature central
nervous system; its dysfunction has been implicated in several neuropsychiatric disorders, …

Subtype-specific cardiomyocytes for precision medicine: Where are we now?

MT Zhao, NY Shao, V Garg - Stem Cells, 2020 - academic.oup.com
Patient-derived pluripotent stem cells (PSCs) have greatly transformed the current understanding
of human heart development and cardiovascular disease. Cardiomyocytes derived …

[PDF][PDF] Patient-specific iPSC-derived endothelial cells uncover pathways that protect against pulmonary hypertension in BMPR2 mutation carriers

M Gu, NY Shao, S Sa, D Li, V Termglinchan, M Ameen… - Cell stem cell, 2017 - cell.com
In familial pulmonary arterial hypertension (FPAH), the autosomal dominant disease-causing
BMPR2 mutation is only 20% penetrant, suggesting that genetic variation provides …

[PDF][PDF] Autologous iPSC-based vaccines elicit anti-tumor responses in vivo

…, PE de Almeida, V Termglinchan, S Diecke, NY Shao… - Cell stem cell, 2018 - cell.com
Cancer cells and embryonic tissues share a number of cellular and molecular properties,
suggesting that induced pluripotent stem cells (iPSCs) may be harnessed to elicit anti-tumor …

Elevated NSD3 histone methylation activity drives squamous cell lung cancer

…, II Wistuba, KF Chua, JA Roth, JD Minna, NY Shao… - Nature, 2021 - nature.com
Amplification of chromosomal region 8p11–12 is a common genetic alteration that has been
implicated in the aetiology of lung squamous cell carcinoma (LUSC) 1 , 2 – 3 . The FGFR1 …

[PDF][PDF] A human iPSC double-reporter system enables purification of cardiac lineage subpopulations with distinct function and drug response profiles

JZ Zhang, V Termglinchan, NY Shao, I Itzhaki, C Liu… - Cell Stem Cell, 2019 - cell.com
The diversity of cardiac lineages contributes to the heterogeneity of human induced pluripotent
stem cell (hiPSC)-derived cardiomyocytes (CMs). Here, we report the generation of a …

[HTML][HTML] Clinical benefit of first-line programmed death-1 antibody plus chemotherapy in low programmed cell death ligand 1–expressing esophageal squamous cell …

…, WL Guan, YX Chen, YC Yao, NY Shao… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
PURPOSE Pembrolizumab or nivolumab plus chemotherapy was approved as a first-line
treatment for high programmed cell death ligand 1 (PD-L1)–expressing esophageal squamous …